UY25330A1 - Nuevos macrólidos - Google Patents

Nuevos macrólidos

Info

Publication number
UY25330A1
UY25330A1 UY25330A UY25330A UY25330A1 UY 25330 A1 UY25330 A1 UY 25330A1 UY 25330 A UY25330 A UY 25330A UY 25330 A UY25330 A UY 25330A UY 25330 A1 UY25330 A1 UY 25330A1
Authority
UY
Uruguay
Prior art keywords
new
birds
mammals
fish
macrolids
Prior art date
Application number
UY25330A
Other languages
English (en)
Inventor
John Philip Dirlam Y Mcarthur
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to UY25574A priority Critical patent/UY25574A1/es
Publication of UY25330A1 publication Critical patent/UY25330A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Se refiere a nuevas eritromicinas y azalidas útiles como agentes antibacterianas y antiprotozoos y en aplicaciones en mamíferos, incluyendo el ser humano, así como en peces y aves. También refiere a composiciones farmacéuticas conteniendo los nuevos compuestos y procedimientos para el tratamiento de las infecciones bacterianas y provocadas por protozoos en mamíferos, peces y aves, mediante administración de los nuevos compuestos a los mamíferos, peces y aves que necesitan dicho tratamiento.
UY25330A 1998-01-02 1998-12-30 Nuevos macrólidos UY25330A1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY25574A UY25574A1 (es) 1998-01-02 1999-06-18 Procedimiento para preparar nuevos macrolidos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7034398P 1998-01-02 1998-01-02

Publications (1)

Publication Number Publication Date
UY25330A1 true UY25330A1 (es) 2000-12-29

Family

ID=22094723

Family Applications (2)

Application Number Title Priority Date Filing Date
UY25330A UY25330A1 (es) 1998-01-02 1998-12-30 Nuevos macrólidos
UY25574A UY25574A1 (es) 1998-01-02 1999-06-18 Procedimiento para preparar nuevos macrolidos

Family Applications After (1)

Application Number Title Priority Date Filing Date
UY25574A UY25574A1 (es) 1998-01-02 1999-06-18 Procedimiento para preparar nuevos macrolidos

Country Status (34)

Country Link
US (2) US6472371B1 (es)
EP (1) EP1044207A1 (es)
JP (1) JP2002500230A (es)
KR (1) KR100352809B1 (es)
CN (1) CN1284081A (es)
AP (1) AP9801420A0 (es)
AR (4) AR014948A1 (es)
AU (1) AU756409B2 (es)
BG (1) BG104644A (es)
BR (1) BR9814601A (es)
CA (1) CA2316919C (es)
CO (1) CO4970821A1 (es)
CZ (1) CZ20002458A3 (es)
DZ (1) DZ2698A1 (es)
EA (1) EA200000594A1 (es)
GT (1) GT199800206A (es)
HR (1) HRP20000442A2 (es)
HU (1) HUP0100420A3 (es)
IL (1) IL137024A0 (es)
IS (1) IS5528A (es)
MA (1) MA24729A1 (es)
NO (1) NO20003347L (es)
NZ (1) NZ504986A (es)
OA (1) OA11438A (es)
PA (1) PA8465301A1 (es)
PE (1) PE20000049A1 (es)
PL (1) PL341642A1 (es)
SK (1) SK9782000A3 (es)
TN (1) TNSN98238A1 (es)
TW (1) TW520374B (es)
UY (2) UY25330A1 (es)
WO (1) WO1999035156A1 (es)
YU (1) YU41500A (es)
ZA (1) ZA9811939B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
EP1754700A3 (en) 1999-01-27 2007-05-09 Kosan Biosciences, Inc. Synthesis of oligoketides
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
AU4354900A (en) 1999-04-16 2000-11-02 Kosan Biosciences, Inc. Ketolide antibacterials
WO2000071557A1 (en) 1999-05-24 2000-11-30 Pfizer Products Inc. 13-methyl-erythromycin derivatives
EP1479687A4 (en) * 2002-02-26 2006-01-04 Meiji Seika Kaisha A NEW LOW-GYLIC CYCLIC AZALIDE, A NEW 16-LOW CYCLIC DIAZALID DERIVATIVE AND METHOD FOR THE PRODUCTION THEREOF
BRPI0515917A (pt) 2004-09-23 2008-08-12 Schering Plough Ltd controle de parasitas em animais pelo uso de novos derivados de éter de oxima de trifluorometanossulfonanilida
MX2007006072A (es) * 2004-11-19 2007-07-11 Schering Plough Ltd Control de parasitos en animales mediante el uso de derivados del parasiticida 2-fenil-3-(1h-pirrol-2-il)acrilonitrilo.
EP1836211B1 (en) * 2004-12-21 2010-03-03 Pfizer Products Inc. Macrolides
EP1890547A2 (en) * 2005-06-09 2008-02-27 Schering-Plough Ltd. Control of parasites in animals by n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US20070238700A1 (en) * 2006-04-10 2007-10-11 Winzenberg Kevin N N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
CA2672795A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
US8084643B2 (en) * 2006-12-13 2011-12-27 Intervet Inc. Water-soluble prodrugs of florfenicol and its analogs
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
HUE037127T2 (hu) 2007-06-27 2018-08-28 Du Pont Állati károkozó irtására szolgáló eljárás
WO2009064953A1 (en) * 2007-11-15 2009-05-22 Enanta Pharmaceuticals, Inc. Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases
TWI401023B (zh) 2008-02-06 2013-07-11 Du Pont 中離子農藥
CA2732017A1 (en) * 2008-07-30 2010-02-04 Intervet International B.V. Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
EP2461684A2 (en) 2009-08-05 2012-06-13 E. I. du Pont de Nemours and Company Mesoionic pesticides
IN2012DN00838A (es) 2009-08-05 2015-06-26 Du Pont
UA110924C2 (uk) 2009-08-05 2016-03-10 Е. І. Дю Пон Де Немур Енд Компані Мезоіонні пестициди
UA107804C2 (en) 2009-08-05 2015-02-25 Du Pont Mixtures of pesticides mezoionnyh
MA34247B1 (fr) 2010-05-27 2013-05-02 Du Pont Forme cristalline du 4-[5-[3-chloro-5-(trifluorométhyl) phényl] -4,5-dihydro-5-(trifluorométhyl)-3-isoxazolyl]-n-[2-oxo-2-[(2, 2,2-trifluoroéthyl) amino] éthyl]-1-naphtalènecarboxamide
WO2012087630A1 (en) 2010-12-20 2012-06-28 E.I. Du Pont De Nemours And Company Pyridine and pyrimidine compounds for controlling invertebrate
AU2012211760A1 (en) * 2011-01-31 2013-08-15 Meiji Seika Pharma Co., Ltd. Novel macrolide derivative
JP2014520151A (ja) 2011-06-20 2014-08-21 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 蠕虫感染を処置するためのヘテロ環式化合物
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
KR20140094026A (ko) 2011-11-28 2014-07-29 이 아이 듀폰 디 네모아 앤드 캄파니 N-(4-퀴놀리닐메틸) 설폰아미드 유도체 및 구충제로서의 이의 용도
WO2013158422A1 (en) 2012-04-17 2013-10-24 E. I. Du Pont De Nemours And Company Heterocyclic compounds for controlling invertebrate pests
WO2014099837A1 (en) 2012-12-18 2014-06-26 E. I. Du Pont De Nemours And Company Sulfonamide anthelmintics
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652537A (en) 1969-11-21 1972-03-28 Lilly Co Eli Epierythromycylamine and epierythromycyl b amine
US3923784A (en) 1973-09-10 1975-12-02 Hoffmann La Roche Erythromycin a derivatives
YU43116B (en) 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4585759A (en) 1985-01-22 1986-04-29 Pfizer Inc. Antibacterial derivatives of a neutral macrolide
HU198913B (en) * 1987-09-03 1989-12-28 Pliva Pharm & Chem Works Process for producing 10-dihydro-10-deoxo-11-aza-erythronolide a-derivatives and pharmaceutical compositions containing them as active components
US5141926A (en) 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
US5824513A (en) 1991-01-17 1998-10-20 Abbott Laboratories Recombinant DNA method for producing erythromycin analogs
WO1993013663A1 (en) 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
US5985844A (en) 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
CA2065218A1 (en) 1991-04-11 1992-10-12 Robert R. Wilkening Process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
US5523399A (en) 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
FR2691464B1 (fr) * 1992-05-21 1995-06-02 Roussel Uclaf Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US6271255B1 (en) 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
AU6932098A (en) 1997-05-09 1998-12-08 Pfizer Products Inc. Erythromycin derivatives
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6407074B1 (en) 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US20020025937A1 (en) 2000-03-20 2002-02-28 Yong-Jin Wu 9-oxime erythromycin derivatives
WO1999000124A1 (en) 1997-06-26 1999-01-07 Merck & Co., Inc. 9a-azalides, compositions containing such compounds and methods of treatment
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
PA8461401A1 (es) 1997-10-29 2000-05-24 Pfizer Prod Inc Derivados de eritromicina triciclicos
HN1998000159A (es) 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
DE69919769T2 (de) 1998-03-03 2005-01-27 Pfizer Products Inc., Groton 3,6-Ketal-Makrolidantibiotika
AU3439899A (en) 1998-06-03 1999-12-20 Pfizer Products Inc. Tricyclic 3-keto derivatives of 6-o-methylerythromycin
US6043227A (en) 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
US6100240A (en) 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
CA2349338C (en) 1998-11-03 2005-12-06 Pfizer Products Inc. Novel macrolide antibiotics
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
WO2000071557A1 (en) 1999-05-24 2000-11-30 Pfizer Products Inc. 13-methyl-erythromycin derivatives
EP1101769A3 (en) 1999-11-18 2001-10-24 Pfizer Products Inc. Nitrogen containing erythromycin derivatives
WO2003014136A1 (en) 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME

Also Published As

Publication number Publication date
CA2316919C (en) 2004-10-26
AU756409B2 (en) 2003-01-09
AR014948A1 (es) 2001-04-11
EA200000594A1 (ru) 2001-04-23
HUP0100420A2 (hu) 2001-07-30
AP9801420A0 (en) 1998-12-31
HRP20000442A2 (en) 2001-04-30
NZ504986A (en) 2003-03-28
GT199800206A (es) 2000-06-21
DZ2698A1 (fr) 2003-03-29
TW520374B (en) 2003-02-11
NO20003347D0 (no) 2000-06-27
MA24729A1 (fr) 1999-07-01
IS5528A (is) 2000-06-09
AR020551A2 (es) 2002-05-15
WO1999035156B1 (en) 1999-10-21
US20040092459A1 (en) 2004-05-13
JP2002500230A (ja) 2002-01-08
AU1444799A (en) 1999-07-26
WO1999035156A1 (en) 1999-07-15
BR9814601A (pt) 2000-10-17
US7015203B2 (en) 2006-03-21
YU41500A (sh) 2003-02-28
EP1044207A1 (en) 2000-10-18
AR020851A2 (es) 2002-05-29
ZA9811939B (en) 2000-06-30
BG104644A (en) 2001-01-31
SK9782000A3 (en) 2001-12-03
IL137024A0 (en) 2001-06-14
PE20000049A1 (es) 2000-02-07
KR100352809B1 (ko) 2002-11-01
CZ20002458A3 (cs) 2001-10-17
PA8465301A1 (es) 2000-09-29
HUP0100420A3 (en) 2003-07-28
AR019787A2 (es) 2002-03-13
CN1284081A (zh) 2001-02-14
CO4970821A1 (es) 2000-11-07
PL341642A1 (en) 2001-04-23
NO20003347L (no) 2000-08-28
OA11438A (en) 2004-04-30
US6472371B1 (en) 2002-10-29
UY25574A1 (es) 1999-09-27
KR20010024818A (ko) 2001-03-26
CA2316919A1 (en) 1999-07-15
TNSN98238A1 (fr) 2005-03-15

Similar Documents

Publication Publication Date Title
UY25330A1 (es) Nuevos macrólidos
CO4970773A1 (es) Nuevos derivados de eritromicina
PA8524501A1 (es) Antibioticos macrolidos
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
AR029383A1 (es) Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes
BR0308289A (pt) Antibióticos do tipo florfenicol
GT199900198A (es) Azalidas de 13 miembros y su uso como agentes antibioticos.
EA199901016A1 (ru) 9-оксим-производные эритромицина
GT199900192A (es) Nuevos antibioticos macrolidos.
AR013001A1 (es) Derivados de la piperazina, procedimientos para prepararlos, las composiciones farmaceuticas que los contienen, su utilizacion como medicamentoy el metodo para tratar enfermedades mediadas por la taquinina.
AR021843A1 (es) Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion.
ES2178761T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas.
ES2163186T3 (es) Composicion que comprende mupirocina y clorhexidina.
PE103799A1 (es) Procedimiento de purificacion de mesilato de alatrofloxacino
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
BRPI0408499A (pt) solução aquosa estável de um fungicida de polieno
ES2128404T3 (es) Derivados de dibekacina y derivados de arbekacina activos contra bacterias resistentes, y la produccion de los mismos.
AR013411A1 (es) Composicion de aplicacion para tratamientos antivirales y afecciones micosicas y/o bacterianas y utilizacion de dichas composiciones.
ES2144154T3 (es) Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica.
BR0006301A (pt) Macrólidos antibacterianos e pró-cinéticos
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
AR028987A1 (es) Compuesto derivado de ciclopentapiridin-cetona, composicion farmaceutica que lo contiene y su uso en la fabricacion de un medicamento util para tratar una enfermedad
AR021463A1 (es) Antibiotico de piridona con perfil de seguridad mejorado
GT199600072A (es) Formas zwitterionicas de trovafloxacina.
GT200000185A (es) Derivados de higromicina.

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20040916